Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT00428376
NCT00428376CompletedNot Applicable

Clinical Trial of Building Block Distribution in Children

University of Washington0 sites200 target enrollmentStarted: September 2005Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
200
Primary Endpoint
Macarthur Bates Language Inventory
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

This is a randomized controlled trial of distributing blocks to children ages 1.5 -2.5 years of age to see if language acquisition improves.

Detailed Description

Children in age group are randomized to get two sets of blocks or not. Outcomes include language development assessed using the Macarthur Bates CDI 6 months after enrollment.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Single Group
Masking
Single

Eligibility Criteria

Ages
18 Months to 30 Months (Child)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •healthy children

Exclusion Criteria

  • •developmental delay, non-English

Outcomes

Primary Outcomes

Macarthur Bates Language Inventory

Secondary Outcomes

  • TV viewing
  • Block play

Investigators

Sponsor Class
Other

Similar Trials

Completed
Not Applicable
Randomised controlled trial (RCT) of a children's hospital at home servicePyrexia, diarrhoea, vomiting, respiratory difficulties
ISRCTN11421664HS R&D Regional Programme Register - Department of Health (UK)399
Withdrawn
Not Applicable
Efficacy of Stellate Ganglion Block in Children With Cerebral Palsy and DysphagiaCerebral Palsy
NCT06211426Zeng Changhao
Not yet recruiting
Not Applicable
Stellate Ganglion Block in Cerebral PalsyCerebral Palsy
NCT06319508Copka Sonpashan80
Recruiting
Phase 3
Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric PatientsIrritability Associated With Autism Spectrum Disorder
NCT06690398Intra-Cellular Therapies, Inc.160
Recruiting
Phase 3
Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder (ASD) in Pediatric PatientsIrritability Associated With Autism Spectrum Disorder
NCT06706674Intra-Cellular Therapies, Inc.160